FDA OKs Cabozantinib for Pancreatic Neuroendocrine Tumors ...Middle East

Medscape - News
FDA OKs Cabozantinib for Pancreatic Neuroendocrine Tumors
Approval was based on findings from the pivotal CABINET trial showing improved PFS and response rates vs placebo. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA OKs Cabozantinib for Pancreatic Neuroendocrine Tumors )

Also on site :